Cargando…

Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction

BACKGROUND: To investigate, using optical coherence tomography angiography (OCT-A), changes in perfusion density and in the foveal avascular zone (FAZ) in eyes with idiopathic vitreomacular traction (VMT) after ocriplasmin injection. METHODS: In this pilot study, we enrolled sixteen VMT eyes treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Iuliano, Lorenzo, Fogliato, Giovanni, Colombo, Roberta, Sacconi, Riccardo, Querques, Giuseppe, Bandello, Francesco, Codenotti, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511184/
https://www.ncbi.nlm.nih.gov/pubmed/31077176
http://dx.doi.org/10.1186/s12886-019-1119-9
_version_ 1783417536642023424
author Iuliano, Lorenzo
Fogliato, Giovanni
Colombo, Roberta
Sacconi, Riccardo
Querques, Giuseppe
Bandello, Francesco
Codenotti, Marco
author_facet Iuliano, Lorenzo
Fogliato, Giovanni
Colombo, Roberta
Sacconi, Riccardo
Querques, Giuseppe
Bandello, Francesco
Codenotti, Marco
author_sort Iuliano, Lorenzo
collection PubMed
description BACKGROUND: To investigate, using optical coherence tomography angiography (OCT-A), changes in perfusion density and in the foveal avascular zone (FAZ) in eyes with idiopathic vitreomacular traction (VMT) after ocriplasmin injection. METHODS: In this pilot study, we enrolled sixteen VMT eyes treated with intravitreal ocriplasmin injection. Sixteen healthy eyes were considered as controls. Macular perfusion density in 3 plexuses [superficial capillary plexus (SCP), deep capillary plexus (DCP), choriocapillaris (CC)] was calculated at baseline and at 1 month after injection. RESULTS: After injection, VMT anatomically resolved in 9 eyes (56.2%), whereas 7 eyes (43.8%) achieved an incomplete VMT separation. Superficial capillary plexus perfusion density was reduced significantly after injection (from 0.427 ± 0.027 to 0.413 ± 0.028; p = 0.0146), while no differences were noted in the DCP (p = 0.2717) nor in the CC (p = 0.6848). Study-eye perfusion density was statistically similar to control eyes in all three plexuses, both at baseline and at follow-up. The FAZ in the SCP area remained unchanged after injection (p = 0.168) but was significantly inferior to controls both at baseline and at 1 month (0.198 ± 0.074 vs. 0.196 ± 0.070; p = 0.007). CONCLUSIONS: Eyes with VMT have a perfusion density comparable to healthy controls, but a smaller FAZ. After ocriplasmin injection the perfusion density in the SCP is reduced, regardless the anatomical success. Limited by the small sample size and the pilot nature of the study, we found microvascular changes after ocriplasmin injection, which may be due to retinal traction release.
format Online
Article
Text
id pubmed-6511184
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65111842019-05-20 Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction Iuliano, Lorenzo Fogliato, Giovanni Colombo, Roberta Sacconi, Riccardo Querques, Giuseppe Bandello, Francesco Codenotti, Marco BMC Ophthalmol Research Article BACKGROUND: To investigate, using optical coherence tomography angiography (OCT-A), changes in perfusion density and in the foveal avascular zone (FAZ) in eyes with idiopathic vitreomacular traction (VMT) after ocriplasmin injection. METHODS: In this pilot study, we enrolled sixteen VMT eyes treated with intravitreal ocriplasmin injection. Sixteen healthy eyes were considered as controls. Macular perfusion density in 3 plexuses [superficial capillary plexus (SCP), deep capillary plexus (DCP), choriocapillaris (CC)] was calculated at baseline and at 1 month after injection. RESULTS: After injection, VMT anatomically resolved in 9 eyes (56.2%), whereas 7 eyes (43.8%) achieved an incomplete VMT separation. Superficial capillary plexus perfusion density was reduced significantly after injection (from 0.427 ± 0.027 to 0.413 ± 0.028; p = 0.0146), while no differences were noted in the DCP (p = 0.2717) nor in the CC (p = 0.6848). Study-eye perfusion density was statistically similar to control eyes in all three plexuses, both at baseline and at follow-up. The FAZ in the SCP area remained unchanged after injection (p = 0.168) but was significantly inferior to controls both at baseline and at 1 month (0.198 ± 0.074 vs. 0.196 ± 0.070; p = 0.007). CONCLUSIONS: Eyes with VMT have a perfusion density comparable to healthy controls, but a smaller FAZ. After ocriplasmin injection the perfusion density in the SCP is reduced, regardless the anatomical success. Limited by the small sample size and the pilot nature of the study, we found microvascular changes after ocriplasmin injection, which may be due to retinal traction release. BioMed Central 2019-05-10 /pmc/articles/PMC6511184/ /pubmed/31077176 http://dx.doi.org/10.1186/s12886-019-1119-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Iuliano, Lorenzo
Fogliato, Giovanni
Colombo, Roberta
Sacconi, Riccardo
Querques, Giuseppe
Bandello, Francesco
Codenotti, Marco
Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
title Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
title_full Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
title_fullStr Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
title_full_unstemmed Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
title_short Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
title_sort reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511184/
https://www.ncbi.nlm.nih.gov/pubmed/31077176
http://dx.doi.org/10.1186/s12886-019-1119-9
work_keys_str_mv AT iulianolorenzo reducedperfusiondensityofsuperficialretinalcapillaryplexusafterintravitrealocriplasmininjectionforidiopathicvitreomaculartraction
AT fogliatogiovanni reducedperfusiondensityofsuperficialretinalcapillaryplexusafterintravitrealocriplasmininjectionforidiopathicvitreomaculartraction
AT colomboroberta reducedperfusiondensityofsuperficialretinalcapillaryplexusafterintravitrealocriplasmininjectionforidiopathicvitreomaculartraction
AT sacconiriccardo reducedperfusiondensityofsuperficialretinalcapillaryplexusafterintravitrealocriplasmininjectionforidiopathicvitreomaculartraction
AT querquesgiuseppe reducedperfusiondensityofsuperficialretinalcapillaryplexusafterintravitrealocriplasmininjectionforidiopathicvitreomaculartraction
AT bandellofrancesco reducedperfusiondensityofsuperficialretinalcapillaryplexusafterintravitrealocriplasmininjectionforidiopathicvitreomaculartraction
AT codenottimarco reducedperfusiondensityofsuperficialretinalcapillaryplexusafterintravitrealocriplasmininjectionforidiopathicvitreomaculartraction